
### [NCIT:C8644](http://purl.obolibrary.org/obo/NCIT_C8644)
**Label:** B Acute Lymphoblastic Leukemia

**Subclasses:** [NCIT:C68659](http://purl.obolibrary.org/obo/NCIT_C68659) (Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1), [NCIT:C128629](http://purl.obolibrary.org/obo/NCIT_C128629) (B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative), [NCIT:C80347](http://purl.obolibrary.org/obo/NCIT_C80347) (B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)), [NCIT:C9140](http://purl.obolibrary.org/obo/NCIT_C9140) (Childhood B Acute Lymphoblastic Leukemia), [NCIT:C80346](http://purl.obolibrary.org/obo/NCIT_C80346) (B Acute Lymphoblastic Leukemia with t(5;14)(q31.1;q32.3); IL3-IGH), [NCIT:C80345](http://purl.obolibrary.org/obo/NCIT_C80345) (Hypodiploid B Acute Lymphoblastic Leukemia), [NCIT:C80344](http://purl.obolibrary.org/obo/NCIT_C80344) (Hyperdiploid B Acute Lymphoblastic Leukemia), [NCIT:C80343](http://purl.obolibrary.org/obo/NCIT_C80343) (B Acute Lymphoblastic Leukemia with t(12;21)(p13.2;q22.1); ETV6-RUNX1), [NCIT:C80342](http://purl.obolibrary.org/obo/NCIT_C80342) (B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged), [NCIT:C36312](http://purl.obolibrary.org/obo/NCIT_C36312) (B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1), [NCIT:C114819](http://purl.obolibrary.org/obo/NCIT_C114819) (Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1), [NCIT:C9143](http://purl.obolibrary.org/obo/NCIT_C9143) (Adult B Acute Lymphoblastic Leukemia), 

**Class expressions from DL-Learner:**

- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 53.84%
- Thing 51.84%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 48.46%
- [NCIT:C36278](http://purl.obolibrary.org/obo/NCIT_C36278) (Finding by Site or System) 47.37%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) 41.61%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C37136](http://purl.obolibrary.org/obo/NCIT_C37136) (Anaplastic Astrocyte))) 41.61%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C37135](http://purl.obolibrary.org/obo/NCIT_C37135) (Neoplastic Astrocyte with Few Flaccid Processes))) 41.61%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C37132](http://purl.obolibrary.org/obo/NCIT_C37132) (Gemistocytic Neoplastic Astrocyte))) 41.61%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C37129](http://purl.obolibrary.org/obo/NCIT_C37129) (Fibrillary Neoplastic Astrocyte))) 41.61%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C37115](http://purl.obolibrary.org/obo/NCIT_C37115) (Serous Adenocarcinoma Cell))) 41.61%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C37108](http://purl.obolibrary.org/obo/NCIT_C37108) (Adenocarcinoma Spindle Cell))) 41.61%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C37091](http://purl.obolibrary.org/obo/NCIT_C37091) (Vacuolated Endothelial Cell))) 41.61%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C37085](http://purl.obolibrary.org/obo/NCIT_C37085) (Undifferentiated Carcinoma Cell))) 41.61%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C37084](http://purl.obolibrary.org/obo/NCIT_C37084) (Hyperchromatic Spindle Cell))) 41.61%
- [NCIT:C50764](http://purl.obolibrary.org/obo/NCIT_C50764) (Lymphadenopathy) and (not ([NCIT:C37078](http://purl.obolibrary.org/obo/NCIT_C37078) (Pseudo-Gaucher Cell))) 41.61%


